Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$32.62 - $40.75 $335,725 - $419,399
-10,292 Reduced 29.4%
24,716 $806,000
Q1 2023

May 15, 2023

SELL
$33.36 - $45.71 $137,443 - $188,325
-4,120 Reduced 10.53%
35,008 $1.23 Million
Q4 2022

Feb 14, 2023

SELL
$35.77 - $51.11 $429,848 - $614,188
-12,017 Reduced 23.5%
39,128 $1.79 Million
Q3 2022

Nov 14, 2022

SELL
$38.54 - $54.52 $63.5 Million - $89.9 Million
-1,648,281 Reduced 96.99%
51,145 $2.48 Million
Q2 2022

Aug 09, 2022

BUY
$33.93 - $48.92 $57.6 Million - $83 Million
1,697,631 Added 94575.54%
1,699,426 $66.8 Million
Q1 2022

May 13, 2022

BUY
$29.74 - $46.0 $50,409 - $77,970
1,695 Added 1695.0%
1,795 $66,000
Q3 2021

Nov 15, 2021

BUY
$18.54 - $35.74 $1,854 - $3,574
100 New
100 $3,000
Q2 2021

Aug 12, 2021

SELL
$19.79 - $26.99 $2.27 Million - $3.09 Million
-114,478 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$18.57 - $25.68 $537,062 - $742,691
-28,921 Reduced 20.17%
114,478 $2.66 Million
Q4 2020

Feb 11, 2021

SELL
$15.26 - $28.61 $1.8 Million - $3.38 Million
-118,115 Reduced 45.17%
143,399 $2.98 Million
Q3 2020

Nov 13, 2020

SELL
$20.58 - $28.96 $166,204 - $233,880
-8,076 Reduced 3.0%
261,514 $5.66 Million
Q2 2020

Aug 13, 2020

BUY
$11.15 - $24.64 $3.01 Million - $6.64 Million
269,590 New
269,590 $6.35 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.61B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.